Agios Pharmaceuticals AGIO Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's debt securities, available-for-sale, unrealized loss position, number of positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's debt securities, available-for-sale, unrealized loss position, number of positions?
- Agios Pharmaceuticals (AGIO) reported debt securities, available-for-sale, unrealized loss position, number of positions of $0 in Q1 2026.